Breitfeld Philip P. 4
4 · CHAMPIONS ONCOLOGY, INC. · Filed Nov 7, 2025
Insider Transaction Report
Form 4
Breitfeld Philip P.
Director
Transactions
- Award
Option to purchase Common Stock
2025-11-05$6.80/sh+13,790$93,772→ 13,790 totalExercise: $6.80Exp: 2035-11-05→ Common Stock (13,790 underlying)
Footnotes (1)
- [F1]The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively.